B
BioTissue Tech Stack
Human tissue products for regenerative medicine and wound care
BioTissue manufactures regenerative medicine products from amniotic and umbilical cord tissues, with clinical adoption across 680,000+ patient treatments documented in peer-reviewed literature. The company's hiring velocity is accelerating, with sales roles dominating new openings (24 of 43 active positions) alongside payer-policy and account-penetration projects — indicating a shift toward commercial scaling rather than clinical validation or manufacturing expansion.
Tech Stack 30 technologies
Core StackPower BI Dynamics 365 NetSuite Smartsheet Palo Alto Networks CrowdStrike Active Directory Windows Server Salesforce Sage X3 Epicor Infor Excel Word PowerPoint Outlook Microsoft Office SPSS Minitab Azure Azure Virtual Machines Azure Files Azure Logic Apps Azure Monitor Ubiquiti UniFi Ubiquiti Microsoft 365 Teams Microsoft Access Google Workspace
What BioTissue Is Building
◆Challenges
- Practice optimization
- Reducing therapy access delays
- Patient outcome improvement
- Penetrating existing accounts
- Removing reimbursement barriers
- Optimizing patient access
- Efficiency improvement
- Dry eye disease management
- New account acquisition
- Increasing donation rates
▲Active Projects
- Develop standardized coding guides
- Lead webinars on payer policies
- Key account business plan development
- Territory business plan development
- Practice integration initiatives
- Expansion of the sharing miracles program
- Monthly regional performance reporting
- Conduct claims reviews
- New program collaboration
- Developing support facilities
Hiring Activity
45 roles · 20 in 30d
Department
Seniority
Notable leadership hires: Director Donation Services, Sales Director
Company intelligence
